Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $10 | $14 | $19 |
| - Cash | $0 | $2 | $0 | $0 |
| + Debt | $3 | $3 | $2 | $1 |
| Enterprise Value | $3 | $10 | $16 | $20 |
| Revenue | $9 | $11 | $11 | $10 |
| % Growth | -21.4% | 0.6% | 14.5% | – |
| Gross Profit | $1 | $3 | $3 | $2 |
| % Margin | 16.3% | 23.5% | 29% | 22.8% |
| EBITDA | $0 | $2 | -$1 | $1 |
| % Margin | 0.5% | 17.8% | -6.4% | 12.8% |
| Net Income | -$5 | $0 | -$2 | $0 |
| % Margin | -59% | 2.8% | -20.6% | 4.1% |
| EPS Diluted | -0.22 | 0.01 | -0.12 | 0.02 |
| % Growth | -2,300% | 108.3% | -700% | – |
| Operating Cash Flow | -$0 | $2 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | $2 | -$1 | -$1 |